osteogenesis imperfecta 使 risedronate:,,

Nick Bishop1, Silvano Adami, S Faisal Ahmed

  • 1Academic Unit of Child Health, Department of Human Metabolism, University of Sheffield, Sheffield Children's Hospital, Sheffield, UK.

Lancet (London, England)
|August 10, 2013
PubMed
概括

口服瑞塞德酸盐通过增加骨矿物质密度和降低骨折风险,有效地治疗儿童的骨质缺陷发生. 这种双酸盐为患有这种疾病的儿科患者提供了耐受性良好的治疗选择.